Medication Treatment of ADHD in Pediatric Epilepsy

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Study ID
NCT07594652
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

  • ADHD - Attention Deficit Disorder With Hyperactivity

Eligibility Criteria

Sex
ALL
Age
6 Years - 17 Years
Healthy Volunteers
Not accepted

Interventions

  • methylphenidate hydrochloride (Jornay PM) — DRUG
    all participants will receive active treatment

Study Details

This is an observational study assessing the usage of stimulant medication for ADHD in the context of pediatric epilepsy.

Key Dates

Start date
May 31, 2026
Status verified
May 2026
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
25 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: interventional arm
    open label flexible dose

Primary Outcome Measure

Clinical Global Impression-Improvement [ Time Frame: 12 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Kennedy Krieger InstituteBaltimoreMaryland21205
Jay Salpekar, MD
[email protected]
443-923-7600

Find similar trials in Baltimore, MD

By research site
Kennedy Krieger Institute· Baltimore, MD

Related Studies